Peginterferon Plus Ribavirin Combination Therapy for Hepatitis C Six Months After Onset of Acute Infection
Status:
Completed
Trial end date:
2016-02-01
Target enrollment:
Participant gender:
Summary
Patients with acute hepatitis C virus (HCV) infection usually become chronicity if viremia
persists after 6 months of infection. The result of using pegylated interferon plus ribavirin
combination therapy upon these patients remains to be explored
Phase:
Phase 4
Details
Lead Sponsor:
Kaohsiung Medical University Chung-Ho Memorial Hospital